Dr. Stephen Graves, Ph.D., DABR

Claim this profile
Studies Neuroendocrine Tumors
Studies Carcinoid Tumor
1 reported clinical trial
1 drug studied

Area of expertise

1Neuroendocrine Tumors
Stephen Graves, Ph.D., DABR has run 1 trial for Neuroendocrine Tumors. Some of their research focus areas include:
Ki-67 positive
Stage IV
2Carcinoid Tumor
Stephen Graves, Ph.D., DABR has run 1 trial for Carcinoid Tumor. Some of their research focus areas include:
Ki-67 positive
Stage IV

Clinical Trials Stephen Graves, Ph.D., DABR is currently running

Image of trial facility.

Lutetium-177 Therapy

for Neuroendocrine Tumors

The goal of this study is to learn if individualized dosimetry-based prescribing of Lutetium-177 DOTATATE (Lutathera, Novartis Pharmaceuticals) improves treatment outcomes for adults with unresectable neuroendocrine tumors. To investigate this, study participants will: * Undergo Somatostatin Receptor (SSTR) positron emission tomography (PET) imaging, such as a DOTATOC PET/CT scan * Be randomized to receive standard treatment (as per FDA guidelines) or investigational treatment (customized dosing of Lutathera based upon dosimetry) * Undergo blood tests for 4 to 8 weeks after each Lutathera treatment * Complete patient reported outcome questionnaires * Visit the clinic for follow-up about every 8 weeks.
Recruiting1 award Phase 24 criteria

More about Stephen Graves, Ph.D., DABR

Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Stephen Graves, Ph.D., DABR has experience with
  • Lutetium Lu 177 Dotatate Therapy
Breakdown of trials Stephen Graves, Ph.D., DABR has run
Neuroendocrine Tumors
Carcinoid Tumor

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Stephen Graves, Ph.D., DABR specialize in?
Stephen Graves, Ph.D., DABR focuses on Neuroendocrine Tumors and Carcinoid Tumor. In particular, much of their work with Neuroendocrine Tumors has involved Ki-67 positive patients, or patients who are Stage IV.
Is Stephen Graves, Ph.D., DABR currently recruiting for clinical trials?
Yes, Stephen Graves, Ph.D., DABR is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Stephen Graves, Ph.D., DABR has studied deeply?
Yes, Stephen Graves, Ph.D., DABR has studied treatments such as Lutetium Lu 177 dotatate therapy.
What is the best way to schedule an appointment with Stephen Graves, Ph.D., DABR?
Apply for one of the trials that Stephen Graves, Ph.D., DABR is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top